P.R. Herzig & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

P.R. Herzig & Co’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,925	Closed	-$1.23M	–	38
2018 Q2	$1.23M	Sell	12,925 -1,670	-11%	-$153K	2.68%	19
2018 Q1	$1.28M	Hold	14,595	–	–	2.57%	19
2017 Q4	$1.24M	Sell	14,595 -400	-3%	-$33.5K	2.38%	19
2017 Q3	$1.3M	Hold	14,995	–	–	2.51%	20
2017 Q2	$1.16M	Sell	14,995 -4,200	-22%	-$298K	2.24%	21
2017 Q1	$1.33M	Buy	19,195 +4,910	+34%	+$330K	2.58%	21
2016 Q4	$846K	Buy	14,285 +600	+4%	+$37K	1.73%	22
2016 Q3	$907K	Buy	+13,685	New	+$847K	1.78%	24

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

P.R. Herzig & Co's XBI Position: Q3 2018 in Review

P.R. Herzig & Co sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2018, closing a stake of 12,925 shares — an estimated $1.23M sold.

P.R. Herzig & Co first reported a position in XBI in Q3 2016 and held it in 8 quarters. The position peaked at $1.33M in Q1 2017. 432 funds tracked by Wall St. Rank hold XBI as of Q3 2018.

P.R. Herzig & Co reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2018 after selling out during the quarter.
P.R. Herzig & Co sold 12,925 State Street SPDR S&P Biotech ETF shares in Q3 2018, an estimated $1.23M.
P.R. Herzig & Co first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and held it in 8 quarters.
P.R. Herzig & Co's State Street SPDR S&P Biotech ETF position peaked at $1.33M in Q1 2017.
432 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2018.

Based on P.R. Herzig & Co's 13F filing for Q3 2018.